Sangart Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
35
- Latest Deal Type
-
M&A
- Investors
-
1
Sangart General Information
Description
Developer of oxygen therapeutics. The company offers Hemospan, a human hemoglobin-based product that delivers oxygen to tissues at risk of oxygen deprivation.
Contact Information
Corporate Office
- 6175 Lusk Boulevard
- San Diego, CA 92121
- United States
Corporate Office
- 6175 Lusk Boulevard
- San Diego, CA 92121
- United States
Sangart Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 31-Dec-2012 | Completed | Clinical Trials - Phase 2 | |||
| 11. Later Stage VC (Series G) | 24-May-2012 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 05-Oct-2010 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series F) | 12-Mar-2009 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series E) | 15-Aug-2006 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 05-Sep-2003 | Completed | Startup | |||
| 6. Later Stage VC (Series D1) | 26-Aug-2003 | Completed | Startup | |||
| 5. Later Stage VC | 19-Jun-2003 | Completed | Startup | |||
| 4. Later Stage VC (Series C) | 25-Feb-2002 | $1.54M | $1.54M | Completed | Startup | |
| 3. Early Stage VC (Series B) | Completed | Startup |
Sangart Comparisons
Industry
Financing
Details
Sangart Competitors (40)
One of Sangart’s 40 competitors is NOVADIP, a Venture Capital-Backed company based in Mont-Saint-Guibert, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NOVADIP | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Cerecin | Venture Capital-Backed | Broomfield, CO | ||||
| Insception Lifebank | Formerly PE-Backed | Mississauga, Canada | ||||
| Vivus | Corporate Backed or Acquired | Campbell, CA |
Sangart Patents
Sangart Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130327677-A1 | Packaging system for preserving a nonoxygenated hemoglobin based oxygen therapeutic product | Active | 15-Mar-2013 | ||
| US-9174771-B2 | Packaging system for preserving a nonoxygenated hemoglobin based oxygen therapeutic product | Active | 15-Mar-2013 | ||
| AU-2014232540-A1 | Polyalkylene oxide valerate hemoglobin conjugates | Active | 15-Mar-2013 | ||
| AU-2014232540-B2 | Polyalkylene oxide valerate hemoglobin conjugates | Active | 15-Mar-2013 | ||
| CA-2906878-A1 | Polyalkylene oxide valerate hemoglobin conjugates | Active | 15-Mar-2013 | A61K38/42 |
Sangart Signals
Sangart Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Banco Humanfond | Venture Capital | Minority | ||
| GZ Group | Venture Capital | Minority | ||
| Gambro Group | Corporation | Minority | ||
| Life Equity Sweden KB | Venture Capital | Minority | ||
| ODIN Forvaltning | Asset Manager | Minority |
Sangart FAQs
-
When was Sangart founded?
Sangart was founded in 1998.
-
Where is Sangart headquartered?
Sangart is headquartered in San Diego, CA.
-
What is the size of Sangart?
Sangart has 35 total employees.
-
What industry is Sangart in?
Sangart’s primary industry is Biotechnology.
-
Is Sangart a private or public company?
Sangart is a Private company.
-
What is Sangart’s current revenue?
The current revenue for Sangart is .
-
How much funding has Sangart raised over time?
Sangart has raised $266M.
-
Who are Sangart’s investors?
Banco Humanfond, GZ Group, Gambro Group, Life Equity Sweden KB, and ODIN Forvaltning have invested in Sangart.
-
Who are Sangart’s competitors?
NOVADIP, Regenxbio, Cerecin, Insception Lifebank, and Vivus are some of the 40 competitors of Sangart.
-
When was Sangart acquired?
Sangart was acquired on 31-Dec-2012.
-
Who acquired Sangart?
Sangart was acquired by Jefferies Financial Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process